IO Biotech, Inc.
IOBT
$0.64
$0.011.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -61.76% | -72.08% | -68.57% | -58.08% | -51.55% |
| Total Receivables | 2.80% | 10.78% | 1.43% | 0.53% | 1.05% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 13.89% | -1.84% | -0.72% | -17.23% | 41.57% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.95% | 73.60% | -20.98% | 68.54% | 198.77% |
| Total Current Assets | -57.29% | -63.79% | -65.89% | -55.89% | -48.74% |
|
|
|||||
| Total Current Assets | -57.29% | -63.79% | -65.89% | -55.89% | -48.74% |
| Net Property, Plant & Equipment | -26.42% | -22.39% | -23.54% | -23.92% | -20.70% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.30% | 11.28% | 3.56% | 7.84% | 5.02% |
| Total Assets | -55.58% | -62.03% | -64.31% | -55.08% | -47.87% |
|
|
|||||
| Total Accounts Payable | 6.30% | 10.39% | 35.36% | 20.19% | -20.90% |
| Total Accrued Expenses | 24.84% | 75.91% | 98.74% | 28.12% | 73.24% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.54% | 13.27% | 10.36% | 9.47% | 10.69% |
| Total Finance Division Other Current Liabilities | -47.60% | -22.82% | -12.15% | -11.19% | 122.57% |
| Total Other Current Liabilities | -47.60% | -22.82% | -12.15% | -11.19% | 122.57% |
| Total Current Liabilities | 14.05% | 44.99% | 65.59% | 23.98% | 23.64% |
|
|
|||||
| Total Current Liabilities | 14.05% | 44.99% | 65.59% | 23.98% | 23.64% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -49.66% | -41.03% | -37.70% | -34.86% | -32.95% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 124.65% | 168.08% | 52.16% | 17.82% | 16.17% |
|
|
|||||
| Common Stock & APIC | 3.12% | 1.58% | 1.60% | 1.60% | 1.59% |
| Retained Earnings | -26.94% | -34.21% | -34.76% | -36.20% | -38.02% |
| Treasury Stock & Other | 34.86% | 29.23% | 30.43% | 29.14% | -11.41% |
| Total Common Equity | -98.74% | -98.35% | -77.12% | -64.69% | -53.95% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -98.74% | -98.35% | -77.12% | -64.69% | -53.95% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -98.74% | -98.35% | -77.12% | -64.69% | -53.95% |
|
|
|||||